This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on SIGN guideline recommendations on managing type 2 diabetes—you will then be prompted to reflect on your learning.
The questions, written by Dr Kevin Fernando, relate to his expert article, Type 2 diabetes: what are the benefits and risks of glucose-lowering agents?, and SIGN 149 guideline on Pharmacological management of glycaemic control in people with type 2 diabetes.
On completion of this activity, you should be able to:
- discuss the current risk/benefit profiles of different drug classes.
- recall a reasonable HbA1c target to reduce the risk of complications in people with type 2 diabetes